Douglas B Fox

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 4

Top Topics

Cell Proliferation

Basal Cell Carcinoma

Top Venues

NPJ precision oncology

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Douglas B Fox, Richard Y Ebright, Xin Hong, Hunter C Russell, Hongshan Guo, Thomas J LaSalle, Ben S Wittner, Nicolas Poux, Joanna A Vuille, Mehmet Toner, Nir Hacohen, Genevieve Marie Boland, Debattama R Sen, Ryan J Sullivan, Shyamala Maheswaran, Daniel A Haber
Downregulation of KEAP1 in melanoma promotes resistance to immune checkpoint blockade. NPJ precision oncology 7 (1) (2023)
Douglas B Fox, Richard Y Ebright, Xin Hong, Hunter C Russell, Hongshan Guo, Thomas J LaSalle, Ben S Wittner, Nicolas Poux, Joanna A Vuille, Mehmet Toner, Nir Hacohen, Genevieve Marie Boland, Debattama R Sen, Ryan J Sullivan, Shyamala Maheswaran, Daniel A Haber
Downregulation of KEAP1 in melanoma promotes resistance to immune checkpoint blockade. NPJ precision oncology 7 (1) (2023)
Douglas B Fox, Richard Y Ebright, Xin Hong, Hunter C Russell, Hongshan Guo, Thomas J LaSalle, Ben S Wittner, Nicolas Poux, Joanna A Vuille, Mehmet Toner, Nir Hacohen, Genevieve Marie Boland, Debattama R Sen, Ryan J Sullivan, Shyamala Maheswaran, Daniel A Haber
Downregulation of KEAP1 in melanoma promotes resistance to immune checkpoint blockade. NPJ precision oncology 7 (1) (2023)
Andrea Walens, Jiaxing Lin, Jeffrey S Damrauer, Brock McKinney, Ryan Lupo, Rachel Newcomb, Douglas B Fox, Nathaniel W Mabe, Jeremy Gresham, Zhecheng Sheng, Alexander B Sibley, Tristan De Buysscher, Hemant Kelkar, Piotr A Mieczkowski, Kouros Owzar, James V Alvarez
Adaptation and selection shape clonal evolution of tumors during residual disease and recurrence. Nature communications 11 (1) (2020)